K. Anderson

3.7k total citations · 2 hit papers
20 papers, 2.7k citations indexed

About

K. Anderson is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, K. Anderson has authored 20 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in K. Anderson's work include Breast Cancer Treatment Studies (7 papers), Gene expression and cancer classification (6 papers) and HER2/EGFR in Cancer Research (5 papers). K. Anderson is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Gene expression and cancer classification (6 papers) and HER2/EGFR in Cancer Research (5 papers). K. Anderson collaborates with scholars based in United States, France and Belgium. K. Anderson's co-authors include Lajos Pusztai, W. Fraser Symmans, Gabriel N. Hortobágyi, Kenneth R. Hess, Roman Rouzier, Jeffrey S. Ross, Nuhad K. Ibrahim, Massimo Cristofanilli, Paolo Morandi and James Stec and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

K. Anderson

20 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

2005 1.4k citations Roman Rouzier, Charles M. Perou et al. Clinical Cancer Research profile →
Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

2006 553 citations Kenneth R. Hess, K. Anderson et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Anderson United States	12	1.6k	1.4k	1.2k	386	278	20	2.7k
Dorthe Grabau Sweden	28	1.6k 1.0×	1.5k 1.1×	1.3k 1.2×	380 1.0×	510 1.8×	57	3.0k
Fanny Piette Belgium	14	1.4k 0.8×	2.0k 1.4×	1.3k 1.1×	228 0.6×	458 1.6×	24	3.4k
Mohammed A. Aleskandarany United Kingdom	36	1.5k 0.9×	1.6k 1.2×	1.7k 1.4×	382 1.0×	510 1.8×	81	3.4k
Hege G. Russnes Norway	23	1.5k 0.9×	1.1k 0.8×	1.6k 1.4×	310 0.8×	397 1.4×	55	3.0k
Véronique Becette France	18	983 0.6×	1.0k 0.7×	889 0.8×	313 0.8×	412 1.5×	56	2.2k
Anne‐Vibeke Lænkholm Denmark	30	1.2k 0.7×	1.2k 0.9×	1.2k 1.0×	276 0.7×	461 1.7×	120	2.6k
Emma C. Paish United Kingdom	26	1.2k 0.8×	2.7k 1.9×	1.2k 1.1×	486 1.3×	538 1.9×	43	4.1k
Elizabeth Mallon United Kingdom	19	1.1k 0.6×	1.0k 0.7×	708 0.6×	443 1.1×	337 1.2×	32	2.0k
Ewan K.A. Millar Australia	33	1.1k 0.7×	1.3k 0.9×	1.8k 1.5×	450 1.2×	525 1.9×	80	3.4k
Alberto Bottini Italy	32	1.5k 0.9×	1.6k 1.2×	1.1k 0.9×	368 1.0×	510 1.8×	117	3.1k

Countries citing papers authored by K. Anderson

Since Specialization

Citations

This map shows the geographic impact of K. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Anderson more than expected).

Fields of papers citing papers by K. Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Anderson. The network helps show where K. Anderson may publish in the future.

Co-authorship network of co-authors of K. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of K. Anderson. A scholar is included among the top collaborators of K. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Anderson. K. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Samur, Mehmet, Raphaël Szalat, Anıl Aktaş Samur, et al.. (2019). S119 THE ROLE OF RECURRENT SOMATIC ALTERATIONS IN THE NON-CODING GENOME WITH FUNCTIONAL IMPLICATIONS IN MM. HemaSphere. 3(S1). 11–12. 1 indexed citations

Magrangeas, Florence, Hervé Avet‐Loiseau, Wilfried Gouraud, et al.. (2012). Minor clone provides a reservoir for relapse in multiple myeloma. Leukemia. 27(2). 473–481. 83 indexed citations

Fischer, Luana, et al.. (2012). 607 PHASE 1/2A STUDIES WITH OCR-002 (ORNITHINE PHENYLACETATE); OPTIMIZED DOSING REGIMEN WITH AN AMMONIA SCAVENGER FOR TREATMENT OF HEPATIC ENCEPHALOPATHY. Journal of Hepatology. 56. S240–S241. 3 indexed citations

Danaee, Hadi, John D. Shaughnessy, P. Leif Bergsagel, et al.. (2008). High-resolution assessment of chromosomal gains and losses in multiple myeloma tumors from bortezomib clinical trial. Journal of Clinical Oncology. 26(15_suppl). 8570–8570. 2 indexed citations

André, Fabrice, Christos Hatzis, K. Anderson, et al.. (2007). Microtubule-Associated Protein-tau is a Bifunctional Predictor of Endocrine Sensitivity and Chemotherapy Resistance in Estrogen Receptor–Positive Breast Cancer. Clinical Cancer Research. 13(7). 2061–2067. 100 indexed citations

Abruzzo, Lynne V., Lynn L. Barron, K. Anderson, et al.. (2007). Identification and Validation of Biomarkers of IgVH Mutation Status in Chronic Lymphocytic Leukemia Using Microfluidics Quantitative Real-Time Polymerase Chain Reaction Technology. Journal of Molecular Diagnostics. 9(4). 546–555. 23 indexed citations

Mazouni, Chafika, Shu‐Wan Kau, D. Frye, et al.. (2007). Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers. Annals of Oncology. 18(5). 874–880. 57 indexed citations

Gong, Yun, Kai Yan, Feng Lin, et al.. (2007). Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study. The Lancet Oncology. 8(3). 203–211. 137 indexed citations

Guo, Ming, et al.. (2007). A Human Papillomavirus Testing System in Women with Abnormal Pap Results. Acta Cytologica. 51(5). 749–754. 9 indexed citations

10.

Peintinger, Florentia, K. Anderson, Chafika Mazouni, et al.. (2007). Thirty-Gene Pharmacogenomic Test Correlates with Residual Cancer Burden after Preoperative Chemotherapy for Breast Cancer. Clinical Cancer Research. 13(14). 4078–4082. 22 indexed citations

11.

Pusztai, Lajos, K. Anderson, & Kenneth R. Hess. (2007). Pharmacogenomic Predictor Discovery in Phase II Clinical Trials for Breast Cancer. Clinical Cancer Research. 13(20). 6080–6086. 42 indexed citations

12.

Anderson, K., Kenneth R. Hess, Mini Kapoor, et al.. (2006). Reproducibility of Gene Expression Signature–Based Predictions in Replicate Experiments. Clinical Cancer Research. 12(6). 1721–1727. 22 indexed citations

13.

Peintinger, Florentia, Henry M. Kuerer, K. Anderson, et al.. (2006). Accuracy of the Combination of Mammography and Sonography in Predicting Tumor Response in Breast Cancer Patients After Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 13(11). 1443–1449. 66 indexed citations

14.

Pusztai, Lajos, Chafika Mazouni, K. Anderson, Yun Wu, & W. Fraser Symmans. (2006). Molecular Classification of Breast Cancer: Limitations and Potential. The Oncologist. 11(8). 868–877. 156 indexed citations

15.

Hess, Kenneth R., K. Anderson, W. Fraser Symmans, et al.. (2006). Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer. Journal of Clinical Oncology. 24(26). 4236–4244. 553 indexed citations breakdown →

16.

Esteva, Francisco J., K. Anderson, Feng Lin, et al.. (2006). Pharmacogenomic analysis of HER2 amplified breast cancer treated with preoperative trastuzumab and paclitaxel, 5-fluorouracil, epirubicin, cyclophosphamide (T/FEC) chemotherapy. Journal of Clinical Oncology. 24(18_suppl). 545–545. 1 indexed citations

17.

Rouzier, Roman, Charles M. Perou, W. Fraser Symmans, et al.. (2005). Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy. Clinical Cancer Research. 11(16). 5678–5685. 1414 indexed citations breakdown →

18.

Perren, Timothy, et al.. (1997). Phase 1 study to investigate alternate sequencing of the combination of gemcitablne and paclitaxel in ovarian carcinoma. European Journal of Cancer. 33. S121–S122. 6 indexed citations

19.

Vinciguerra, V., K. Anderson, & O. Ross McIntyre. (1985). Diaziquone for resistant multiple myeloma. Cancer and Leukemia Group B.. PubMed. 69(3). 331–2. 2 indexed citations

20.

Anderson, K.. (1978). Seasonal change in fine structure and function of Leydig cells in the blue fox (Alopex lagopus). Andrology. 1. 424–439. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact